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Background: Primary lymphoepithelial-like carcinoma of the parotid gland is a rare tumour with an increased
incidence among Eskimos and Orientals. In these populations, it is usually associated with Epstein-Barr virus. In
Western countries, salivary gland lymphoepithelial-like carcinomas are uncommon and only 14 cases have been
described so far; among these, only five cases showed Epstein-Barr virus positivity.
Case report: A 45-year-old woman was admitted to Siena Hospital for evaluation of a pre-existent (2 years) painless
and tender submandibular mass, rapidly enlarging since two months. On physical examination, a 2.5-cm mass was
found in the right parotid. It was firm, mobile and non-tender. Laboratory data were within reference range.
Nuclear magnetic resonance detected a 2,5×1,5×1-cm well-circumscribed mass in the deep lobe of the right
parotid. A total right paroditectomy with dissection of a satellite lymph node was performed. On the basis of
morphological, immunohistochemical and molecular biology findings, a diagnosis of stage II (according to TNM7)
Epstein Barr-virus positive, undifferentiated lymphoepithelial-like carcinoma of the parotid gland was made. Twenty
months after surgery the patient was free of disease.
Conclusions: Further studies seem to be necessary to completely elucidate the oncogenic role of Epstein Barr-virus
in these tumors, which have identical morphology but different prognosis and variable presence of the virus.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1260381551000616Background
Salivary gland neoplasms comprise less than 3% of all
neoplasms in the head and neck region [1]. Eighty per-
cent occur in the parotid gland, of which approximately
80% are benign and 20% are malignant [2]. An exception
is represented by the Eskimo population, in which 60%
of the parotid gland tumors are malignant, the majority
being lymphoepithelial-like carcinoma (LELC) [3]. LELC
is analogous to lymphoepithelial carcinoma (LE) of the
nasopharynx which is very common among Southern
China inhabitants [1]. LE is a poorly differentiated car-
cinoma composed of sheets of large atypical epithelial
cells intermingled with a benign inflammatory infiltrate* Correspondence: maradot@libero.it
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reproduction in any medium, provided the orthat is rich in lymphocytes and plasma cells. It is equiva-
lent to type 3 nasopharyngeal carcinoma according to
the World Health Organization (WHO) classification
[4]. A consistent feature is the association of this type of
carcinoma with Epstein-Barr virus (EBV), which is de-
tectable in all tumour cells [5]. LELC has the same histo-
logical patterns as undifferentiated LE and is associated
with a variable amount of lymphoid infiltrate in the
stroma. However, LELC arises in organs other than
nasopharynx, including larynx [6], tonsils [7], salivary
glands [8], lung [9], thymus [10], stomach and duode-
num [11], breast [12], renal pelvis and urinary bladder
[13], uterine cervix [14], endometrium [15-17] ovary
[18,19], vulva and vagina [20-22]. EBV is detected in
LELCs arising in organs of foregut derivation and
in Asian women but rarely in LELCs of other sites or in
non-Asian patients [6-22]. When the tumors occurral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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volved [23]. Women are affected more than men with an
average age of 40 years (range: 20–60 years) [24]. Two
thirds of LELC arise de novo, whereas the remaining de-
velop in the setting of a preceding or concurrent benign
lymphoepithelial lesion [25]. To the best of our know-
ledge, 14 cases [1,4,25-32] of this unusual cancer occur-
ring in the salivary glands have been described in
Western population and only in five cases EBV encoded
RNAs (EBER) was positive [26-28]. Herein, we present
the sixth case associated with EBV infection and the first
one showing LMP-1 positivity.Case presentation
Ethics Statement
Ethics approval for this study was obtained from the
Institutional Review Board at the University of Siena
(Italy).Clinical summary
A 45-year-old woman was admitted to Siena University
Hospital for evaluation of a pre-existent (2 years) pain-
less and tender submandibular mass, rapidly enlarging
since two months. She denied any history of facial weak-
ness, cervical lymphadenopathy, or recent fever, tooth
extraction or trauma. Her medical and family history
was unremarkable. On physical examination, a 2.5-cm
mass was found in the right parotid. It was firm, mobile
and non-tender. Facial nerve function was intact and
no enlarged cervical lymph node or other masses
were palpated. Examination of the nasopharynx and
Waldeyer’s ring by nasopharingoscopy found no lesions.
Laboratory data were within reference range. Nuclear
magnetic resonance (NMR) detected a 2,5×1,5×1-cm
well-circumscribed mass in the deep lobe of the right
parotid. A total right paroditectomy with dissection of a
satellite lymph node was performed.Figure 1 Histopathological characteristics of the LELC of the parotid g
immersed in an abundant lymphoid tissue. (B) The neoplastic sheets are co
mitotic figure are observed. [A-C Haematoxylin-Eosin (H&E). A, Original MagPathologic findings
At gross examination, the parotid gland appeared almost
entirely substituted by a yellowish white, firm and
multinodular lesion measuring 2.5×1.6×1.2 cm. Macro-
scopically, the tumor did not involve surgical margins.
Representative sections of the surgical specimen were
performed, routinely processed, stained with haematoxy-
lin and eosin and examined by light microscopy. Micro-
scopically, solid carcinomatous sheets, trabeculae and
isolated small groups of neoplastic epithelial cells
intermingled with lymphoid tissue and surrounded by
fibrous tissue were observed [Figure 1A]. The carcin-
omatous areas were sometimes characterized by
crowded and overlapping syncitial-appearing large
tumor cells with scant amphophilic cytoplasm and ves-
icular haphazardly arranged nuclei [Figure 1B]. Nuclei
had diameters up to 8 times the diameter of lymphocyte
nuclei and sharply demarcated nuclear rims, finely
speckled chromatin and prominent, usually single,
eosinophilic nucleoli. There were nuclear atypia and
numerous mitotic figures [Figure 1C]. Minute areas of
coagulative necrosis were present. The lymphoid infil-
trate was composed mainly of small lymphocytes and, in
some areas, formed follicular structures with germinal
centers. The density of lymphoid tissue varied from
areas with a few lymphocytes and plasma cells in be-
tween carcinomatous islands or accompanying carcin-
omatous trabeculae to areas where abundant lymphoid
cells broke the tumor islands into small groups of cells.
The surrounding parotid tissue contained foci of chronic
sialoadenitis and scattered benign lymphoepithelial le-
sion. The satellite lymph node showed no infiltration by
the tumor.
Immunohistochemistry analysis showed that the
carcinomatous cells were decorated by cytokeratin 7,
LMP-1 and Fascin [Figure 2A-C] as well as by vimentin,
whereas they were negative for cytokeratin 20 and
lymphoid markers. The proliferation index (Mib-1) was
about 80%. The lymphoid tissue contained a mixture ofland. (A) Isolated small groups of carcinomatous cells (arrows) are
mposed of syncytial-like cells. (C) Nuclear atypia and numerous
nification (O.M.): 5x; B, O.M.: 10x; C, O.M.: 20x].
Figure 2 Immunohistochemichal analysis of the carcinomatous component of the lesion. Carcinomatous sheets showed positivity to (A)
CK20, (B) LMP-1 and (C) fascin. (A, O.M.: 10x; B and C, O.M.: 40x).
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positive) (Figure 3B) and follicles with CD10-positive
germinal centers. Numerous CD30 positive blasts were
present. EBER-positive signals were observed in both the
carcinomatous and lymphoid cells (Figure 3C).
On the basis of morphological, immunohistochemical
and molecular biology findings, a diagnosis of stage II
(according to TNM7) EBV-positive, undifferentiated
LELC of the parotid gland was made. Twenty months
after surgery the patient is free of disease, as confirmed
by NMR.
Discussion
The term lymphoepithelioma was introduced in 1921 to
refer to an undifferentiated carcinoma of the nasophar-
ynx with a dense lymphocytic component [33]. It is
characterized by nests of undifferentiated epithelial cells
infiltrated by a prominent benign reactive lymphocytic
infiltrate. Epstein-Barr virus is frequently present in the
malignant epithelial cells of this carcinoma [17]. Such
association was first reported by Harold Zur Hausen in
1970 [19]. LELC is a subtype of poorly differentiated
squamous cell carcinoma, identical to the LE described
in the nasopharynx but originating in other anatomic
sites. Most of the reported cases of primary LELC of the
salivary gland occurred in Asians and Eskimos whereas
they are uncommon in Americans and Europeans [26].
To the best of our knowledge, 14 cases have been previ-
ously described in western people [1,4,25-32]. All lesions
affected parotid gland. The median age of the patientsFigure 3 Immunohistochemichal analysis of the lymphoid componen
positive. (C) EBER positive signals were observed in both carcinomatous anwas 54,6 years (range: 32–74), with a female predomin-
ance (78.5%). Six patients (43%) showed lymph node me-
tastasis (not all data available). Only two patient (14%)
received radiation therapy alone, the others being treated
by total parotidectomy with or without postoperative ra-
diation therapy. All the patients were alive at the last
follow-up (not all data available). In situ hybridization
for EBV was positive only in 5 patients (36%, not all data
available). Clinico-pathological and therapy data of all
these 14 cases are listed in Table 1.
The origin and pathogenesis of LELC is still unknown
[1]. It is thought to arise in either of two settings: malig-
nant transformation of a myoepithelial island or malig-
nant transformation of glandular and ductal inclusions
in intraparotid lymph node. The association with EBV
has suggested a possible role for the virus in the etiology
but the relationship is controversial, considering that
some LELC at specific anatomical sites have never been
proven to be associated with EBV [17]. There is no satis-
factory explanation for EBV being commonly present in
certain anatomic sites, but not in others. In the past, it
was believed that only foregut-derived organs (salivary
gland, stomach, thymus, and lung) were susceptible to
EBV-associated carcinogenesis, perhaps because these
organs are in close proximity to sites of natural viral rep-
lication [19]. The portal of entry of the virus is thought
to be the oropharyngeal mucosa, which also serves as
the site of production of the virus, which is periodically
shed in saliva [27]. The infection of lymphocytes permits
systemic dissemination, and following primary infection,t of the lesion. Lymphoid cells were (A) CD3 positive and (B) CD20
d lymphoid areas (A and C, O.M.: 20x; B, O.M.: 10x).
Table 1 Clinicopathological features of patients with LELC of the parotid gland described in the Western literature
Author Sex Age Treatment Clinical outcome EBER Other data
Ferlito A, 1977 [30] F 36 SP At the last follow-up, no signs of relapse n.a. Cervical lymph node metastasis
Ferlito A, 1977 [30] F 55 SP At the last follow-up, no signs of relapse n.a. n.a.
Ferlito A, 1977 [30] F 32 RP At the last follow-up, no signs of relapse n.a. n.a.
Kott ET, 1984 [31] M 51 RT At 11-year follow-up, no signs of relapse n.a. Cervical lymph node metastasis
Kott ET, 1984 [31] F 42 SP + RT At 12-month follow-up, no signs of relapse n.a. n.a.
Kountakis Se,1995 [1] F 68 SP + RT At 24-month follow-up, no signs of relapse negative Metastasis to intraparotid lymph node
Kountakis Se, 1995 [1] F 57 RP + RT At 24-month follow-up, no signs of relapse negative Lymph node metastasis
Kotsianti A, 1996 [32] M 64 SP At the last follow-up, no signs of relapse positive Regional lymph node metastasis
Squillaci S, 2000 [27] F 45 SP + RT At 15-month follow-up, no signs of relapse positive n.a.
Wu DL, 2001 [26] F 54 RP + RT At 24-month follow-up, no signs of relapse positive n.a.
Squillaci S, 2002 [4] F 72 SP + RT At 36-month follow-up, no signs of relapse positive Periparotid lymph node metastasis
Bialas M, 2002 [28] F 74 RT n.a. positive n.a.
Ayache S, 2004 [25] M 47 RP + RT At 7-month follow-up, no signs of relapse negative Neural metastasis
Manganaris A, 2007 [29] F 67 SP + RT At 12-month follow-up, no signs of relapse n.a. n.a.
RP radical parotidectomy, SP superficial parotidectomy, RT radiotherapy, n.a. not available.
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life. The establishment of a persistent infection protects
the virus against the immune response. Thus, EBV can
immortalize human keratinocytes promoting neoplastic
transformation. The oncogenic role of EBV is elicited by
its products. Among these, LMP-1 has a driving role.
Expression of LMP-1 prevents apoptosis, induces abnor-
mal cell proliferation, deregulates epithelial growths and
inhibits differentiation, with the epithelial cells showing
the features of transformed cells [34]. However, the
expression of this protein was observed only in few EBV-
linked salivary LELC from Asian patients and our case is
the first one in which LMP-1 positivity was detected in a
Western patient. These findings may suggest that different
strains of EBV could be involved in the pathogenesis of
salivary LELC in different geographic areas. These strands
may express LMP-1 with different genetic sequence and
thus different immunohistochemical positivity [35]. A re-
cent study has reported the immunoreactivity of LELC
neoplastic cells for fascin as in our case [4]. Fascin is a 55
Kda globular protein that is expressed in almost all cellular
types. It acts organizing actin-based structures (i.e. filo-
podia, microspikes and lamellipodial ribs), and cytoplas-
mic microfilament bundles [36,37]. In addition fascin
packs F-actin into parallel bundles. The association of
fascin with F-actin is strongly regulated by the extracellu-
lar matrix (ECM) environment of cells and is required for
cell migration [38,39]. It is possible that latent EBV infec-
tion of epithelial salivary gland cells can upregulate tran-
scriptional activity of the fascin-1 gene with increased
synthesis of the protein in cytoplasm. This phenomenon
could play an important role in the progression to an inva-
sive phenotype of transformed cells, with the loss of cell tocell adhesion and loss of junctional communications. Fur-
thermore, fascin-positive stromal dentritic cells might be
modified by functional changes via the EBV induced re-
lease of soluble CD83 with inhibition of stimulation of
T-cell proliferation [39]. However, the absence of EBV
genome in most LELC cases [19] implies that EBV is not a
necessary factor in the aetiology or pathogenesis of LELC,
and that genetic, environmental or geographic factors may
be involved [17].
Differential diagnosis of LELC include squamous and
mucoepidermoid carcinoma with abundant lymphocytic
infiltration, poorly differentiated large cell carcinoma of
salivary origin, and nasopharyngeal carcinoma with
parotid extension. The first three entities are easily dis-
tinguished from LELC by histology. Otherwise, nasopha-
ryngeal carcinoma can be difficult to differentiated and
requires a complete clinical, radiological, morphological
and immunohistochemical evaluation [27].Conclusion
We presented a case of EBV-positive LELC of the parotid
gland with a brief review of the literature. On the basis of
our findings, further studies seem to be necessary to com-
pletely elucidate the oncogenic role of EBV in these tu-
mors, which have identical morphology of nasopharyngeal
LE but different prognosis and variable presence of the
virus. When stratified according to stage, LELC has a
more favorable outcome. This is probably due to the pres-
ence of prominent lymphoid tissue, which may represent
a host response against the tumour, and to its biological
characteristics, including responsiveness to radiotherapy.
Biologic significance of EBV in LELC is unclear as well as
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bers of cases and short follow-up [17].
As previous studies demonstrated that fascin is a
downstream mediator of LELC carcinogenesis, it may
represent a molecular target for therapeutic intervention
[4]. An analysis of additional cases with long-term
follow-up as well as systematic evaluation of fascin ex-
pression would be necessary to shed new light on the
pathogenesis of this rare and challenging tumour.
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